◆ 会议时间：2025年2月5-7日
◆ 会议地点：美国 洛杉矶

◆ 会议简介：

2025年国际卒中大会(ISC2025)将于2025年2月5-7日在美国洛杉矶举行，会议由美国心脏协会(AHA)/美国卒中协会(ASA)主办。国际卒中大会(ISC)是世界上最大的致力于脑血管疾病科学与治疗的学术会议，预计有来自全球50多个国家和地区的5000余名卒中和脑血管专家及相关人士参加会议。

美国心脏协会(AHA)成立于1924年，是全球影响力最大、历史最悠久的非盈营性权威心血管学术组织宣，致力于心脏病和卒中的预防与治疗，拥有2250万志愿者和支持者。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

ISC 2025 - International Stroke Conference

Date:
Pre-Con Sessions: February 4, 2025
ISC Sessions: February 5–7, 2025

Venue:
Los Angeles Convention Center
Los Angeles, CA, USA

The International Stroke Conference is the world's largest meeting dedicated to the science and treatment of cerebrovascular disease.

摘要征文投稿：

Deadlines

ISC, Stroke Nursing Symposium, and HEADS-UP Abstract Submission Deadline:
Tuesday, August 20, 2024 at 11:59 pm EDT.

ISC Trainee Abstract Submission Deadline:
September 30, 2024, 11:59 pm EDT.

Submission Fees

• AHA Professional Member Members: $45
• Nonmembers $95

Watch this space for Late-Breaking Science and Ongoing Clinical Trials submission opportunities, open October 2–30, 2024.

点此提交摘要>>>Submit Abstract>>>

Request for Abstract Withdrawl (in writing):
November 30, 2024

Abstract Submission Rules & Guidelines

Rules for Submission of Abstract(s)

Author Name(s)

1. If an author's name appears on more than one abstract, it must be identical on each abstract.
2. The submitting author is designated as the presenting author. You may change who is presenting the abstract in the “Authors” step of the submission site. You may rearrange the order of the authors; however, the senior author must always be listed last. The presenter must be an author of the abstract.
3. There is no limit to the number of abstracts an investigator may submit. If selected, the presenter must be one of the co-authors listed. If multiple submissions are accepted, the presenting author must resolve schedule conflicts by arranging for a co-author to present.
4. Additions or deletions of author names will not be permitted after August 20, 2024, 11:59 pm EDT.

Abstract Data

1. Abstract data may not be presented at any national or international meeting held prior to the date and time of presentation or time of AHA news event.
2. The International Stroke Conference 2025 is a forum for the presentation of novel research findings. Thus, the work covered by the abstract must not have been published (manuscript or abstract) prior to the time of abstract submission. Abstracts associated with a manuscript published between the time of submission and time of presentation may still be presented at ISC 2025 but will not be included in the Stroke journal abstract publication. Authors must contact AHA staff to be removed from the abstract publication prior to the event. Please notify AHA staff by sending an e-mail to stroke.program.participant@heart.org.
3. Authors should not "split" data to create several abstracts from one. If splitting is judged to have occurred, priority scores of related abstracts will be reduced.
4. Abstracts containing identical or nearly identical data submitted from the same institution and/or individuals will be disqualified.
5. Because of the large number of submitted abstracts, resubmission of an abstract to make revisions is not permitted after August 20, 2024, 11:59 pm EDT.
6. To ensure that the abstract receives proper scientific consideration, please make sure that the abstract is submitted to the appropriate category. A list of the abstract categories and their definitions is available on the submission site.
7. Proofread abstracts carefully to avoid errors before submission. No proof pages will be sent to authors. Revisions to abstracts will not be permitted after the August 20, 2024, 11:59 pm EDT submission deadline.

Use of Automated Assistive Writing Technologies and Tools

1. The use of automated assistive writing technologies and tools (commonly referred to as artificial intelligence or machine learning tools) is permitted provided that their use is documented, and authors assume responsibility for the content. As with human-generated content, authors are responsible for the accuracy, validity and originality of computer-generated content. Automated assistive writing technologies do not qualify for authorship as they are unable to provide approval or consent for submission.
2. If the use of these technologies has involved the research design, the tools should be documented in the Methods. For additional information, see the World Association of Medical Editor recommendations.
3. For your abstract submission, you will need to indicate the use of these tools.

Abstract Title

1. An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.

Abstract Text

1. Describe briefly the objectives of the study unless they are contained in the title. Include a brief statement of methods. State findings in detail sufficient to support conclusions. Abstracts should not describe research in which the chemical identity or source of the reagent is proprietary or cannot be revealed.
2. Abstracts may have the following identifiable sections, but they are not mandatory: Introduction, Hypothesis, Methods, Results and Conclusions. You may include a hypothesis, but only if it is appropriate to do so.
3. The abstract must contain a brief section on Methods/Methodology.
4. Use generic drug names.
5. Do not begin sentences with numerals.
6. Standard abbreviations may be used without definition. Non-standard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
7. Do not include author or institution names, references, credits or grant support in the abstract.
8. Do not include the names or personal information of any patient participating in the study or trial.
9. Abstracts are limited to 2,500 characters (about 500 - 600 words). This includes spaces and punctuation. It does not include graphics. Only 3 graphics max per abstract are allowed.
10. Tables must be submitted as graphics. Do not submit a table in Word as it will not format correctly in the online Stroke journal.
11. Due to new accessibility guidelines, you must submit a brief description of any and all graphics included in your abstract submission in the appropriate step on the submission site.

Graphics Guidelines

1. All graphics (figures) and text-based graphics (tables) should be provided as 72 - 300 dpi; pre-sized .BMP, .GIF, .JPG, or .PNG images only, with a maximum width of 440 pixels (no limit on length). Black-and-white digital images should be in grayscale mode. Color images should be saved in RGB color mode.
2. Only 3 graphics max per abstract are allowed.
3. All graphics will require a brief description of the image.
4. Please Note: If an abstract is accepted for publication, any images submitted with the abstract are placed after the abstract text that will appear in the online only Stroke journal, an American Heart Association journal.

Abstract Revisions

1. After the August 20, 2024, 11:59 pm EDT deadline, abstracts may not be revised in any way or resubmitted.
2. Additions or deletions of author names will not be permitted after August 20, 2024, 11:59 pm EDT.
3. Proofread abstracts carefully to avoid errors before submission.

Abstract Copyright Transfer Agreement

Abstract Copyright Transfer Agreement will be electronically signed during submission.

• Your selection of “Yes” will grant permission to publish.
• Your selection of “No” will prohibit publication of the abstract in all formats including the online Stroke journal, ePoster site, the mobile meeting guide app, and the online program planner.

Acceptance

1. Abstracts selected will be published online in February 2025 on the Stroke Journal web site.
2. All communications regarding your abstract will be sent from International Stroke Conference 2025 (onbehalfof@abstractcentral.com). Please make sure to add this e-mail address to your e-mail contacts to ensure important program participant related information gets through your spam filters, etc.
3. If the abstract is submitted to more than one meeting, investigators must include new and scientifically meaningful information/results at time of submission to the AHA.
4. Abstracts accepted for presentation at ISC 2025 cannot be presented at another national or international meeting held prior to February 7, 2025.
5. The work covered by the abstract must not be published prior to the time of abstract submission. Abstracts associated with a manuscript published between the time of submission and time of presentation may still be presented at ISC 2025 but will not be included in the Stroke journal abstract publication. Authors must contact AHA staff to be removed from the abstract publication prior to the event. Please notify AHA staff by sending an e-mail to stroke.program.participant@heart.org.
6. Abstract grading is blinded. Abstracts are selected on the basis of scientific merit and are allocated to oral or poster presentations.
7. Guidelines for presentations will be provided to authors of accepted abstracts.
8. Abstract acceptance/non-acceptance status will be e-mailed to the submitting author in late October to the e-mail address provided during the submission process.

Abstract Journal Publication

Accepted abstracts having selected “Yes” to the Abstract Copyright Transfer Agreement will be published online in the Stroke journal.

Embargo Policy

Non-late breaking abstracts and presentations are embargoed for release at 5 a.m. ET, Thursday, January 30, 2025, and are therefore prohibited from release until date and time of AHA designated embargo time. You will be contacted by AHA communications if you are selected to participate in an AHA news event.

Written embargoed information cannot be shared with anyone outside of the AHA with the exception of a journal manuscript where one-on-one embargoed media interviews can be conducted as long as the reporter agrees to abide by the embargo policy. Failure to honor embargo policies will result in this abstract being withdrawn and future abstracts also being barred from presentation.

Abstracts associated with a manuscript published between the time of submission and time of presentation may still be presented at ISC 2025 but will not be included in the Stroke journal abstract publication. Authors must contact AHA staff to be removed from the abstract publication prior to the event. Please notify AHA staff by sending an e-mail to stroke.program.participant@heart.org.

Complete AHA Embargo Policy

Presentation

1. Request “oral or poster” or “poster only” preferred presentation on the Properties tab of the Submitter Site. The selection of one of these options will neither prejudice acceptance nor guarantee an oral or poster presentation because abstracts must be arranged to fit into a thematic group for presentation.
2. All presentations and question-and-answer sessions will be conducted in English. Presenters may request assistance from the moderator who will repeat or rephrase questions from the audience, or they may ask a colleague in the audience to help translate.
3. Submission of an abstract constitutes a commitment by the author(s) to present it if accepted. Failure to present, if not justified, will jeopardize future acceptance of abstracts.
4. The American Stroke Association, a division of the American Heart Association, reserves the right to all video or audio recordings of presentations at the International Stroke Conference 2025.
5. The presenter is responsible for all expenses associated with the submission and presentation of an abstract (e.g. registration, airfare, lodging, etc.).
6. All oral presentations must be in electronic format. Electronic presentations must be submitted via the Presentation Management system at least 12 hours in advance of the session start time. Instructions will be sent to the presenting author via e-mail in early January 2025.
7. If you are referencing work previously published by another author, please be sure to include a complete citation at the bottom of the appropriate slide.

Recording Policy

1. Unauthorized recording of the AHA Scientific Sessions, scientific conferences, and the AHA/ASA International Stroke Conference and ISC Pre-Conference Symposia is prohibited, whether by video, still or digital photography, audio or any other recording or reproduction mechanism. This includes recording of presentations and supporting audiovisual materials and of poster presentations and supporting poster materials.
2. The American Heart Association and American Stroke Association reserve the rights to all recordings or reproductions of presentations at AHA/ASA scientific conferences and meetings.

Abstract Withdrawal

1. Requests for withdrawal of an abstract must be received in writing by November 30, 2024.

ISC2025 注册费：